{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:07:06Z","timestamp":1790662026780,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.critrevonc.2023.103926","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:43:14Z","timestamp":1675312994000},"page":"103926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment"],"prefix":"10.1016","volume":"183","author":[{"given":"Sabine","family":"Karam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Haidous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman Abou","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Dendooven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Moukalled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaryllis","family":"Van Craenenbroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2018.03.017","article-title":"Congophilic fibrillary glomerulonephritis: a case series","volume":"72","author":"Alexander","year":"2018","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1681\/ASN.2007070757","article-title":"Fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"19","author":"Alpers","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib3","first-page":"243","article-title":"Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options","volume":"77","author":"Amaador","year":"2019","journal-title":"Neth. J. Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103926_bib4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/leu.2013.29","article-title":"Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety","volume":"27","author":"Badros","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2023.103926_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805697","article-title":"New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?","volume":"13","author":"Basu","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbmt.2017.08.031","article-title":"High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease","volume":"24","author":"Batalini","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clml.2015.12.007","article-title":"Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study","volume":"16","author":"Berdeja","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ekir.2017.07.008","article-title":"Membranous glomerulopathy with light chain-restricted deposits: a clinicopathological analysis of 28 cases","volume":"2","author":"Best Rocha","year":"2017","journal-title":"Kidney Int Rep."},{"issue":"Pt 5","key":"10.1016\/j.critrevonc.2023.103926_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0004563213518758","article-title":"Serum-free light-chain assay: clinical utility and limitations","volume":"51","author":"Bhole","year":"2014","journal-title":"Ann. Clin. Biochem"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mayocp.2015.01.024","article-title":"Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits","volume":"90","author":"Bhutani","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.ajkd.2004.09.029","article-title":"Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1\/alpha2 chains of type IV collagen","volume":"45","author":"Borza","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"9356","key":"10.1016\/j.critrevonc.2023.103926_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(03)12457-9","article-title":"Serum test for assessment of patients with Bence Jones myeloma","volume":"361","author":"Bradwell","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib13","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib14","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.kint.2016.09.004","article-title":"Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management","volume":"91","author":"Bridoux","year":"2017","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am. J. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.20643","article-title":"Natural history and therapy of 66 patients with mixed cryoglobulinemia","volume":"81","author":"Bryce","year":"2006","journal-title":"Am. J. Hematol."},{"issue":"52","key":"10.1016\/j.critrevonc.2023.103926_bib19","article-title":"Acute renal failure in a patient with PR3-ANCA and monoclonal immunoglobulin deposition disease","volume":"97","author":"Cassol","year":"2018","journal-title":"Case Report. Med. (Baltim. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bjh.13794","article-title":"Rituximab intolerance in patients with Waldenstrom macroglobulinaemia","volume":"174","author":"Castillo","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103926_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","article-title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy","volume":"129","author":"Chauvet","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ki.2015.201","article-title":"Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease","volume":"88","author":"Cohen","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.ajkd.2014.08.022","article-title":"Monoclonal IgG1kappa anti-glomerular basement membrane disease: a case report","volume":"65","author":"Coley","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40265-020-01311-1","article-title":"Isatuximab: First Approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib27","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-06-860015","article-title":"Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR","volume":"133","author":"Dimopoulos","year":"2019","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.critrevonc.2023.103926_bib28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1607751","article-title":"Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma","volume":"375","author":"Dimopoulos","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.critrevonc.2023.103926_bib29","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa1802917","article-title":"Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia","volume":"378","author":"Dimopoulos","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2005.05.004","article-title":"Focal and segmental glomerulosclerosis and plasma cell proliferative disorders","volume":"46","author":"Dingli","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib31","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2006-04-015784","article-title":"Immunoglobulin free light chains and solitary plasmacytoma of bone","volume":"108","author":"Dingli","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000181970","article-title":"Relapsing Henoch-Schonlein syndrome with renal involvement in a patient with an IgA monoclonal gammopathy. A study of the results of immunosuppressant and cytotoxic therapy","volume":"26","author":"Dosa","year":"1980","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib34","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","article-title":"Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome","volume":"25","author":"El Hamel","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"(Light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.critrevonc.2023.103926_bib36","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.critrevonc.2023.103926_bib37","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0272-6386(99)70084-3","article-title":"Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody","volume":"34","author":"Fervenza","year":"1999","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib39","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/s41375-018-0209-7","article-title":"European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias","volume":"32","author":"Gavriatopoulou","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib40","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ajh.26569","article-title":"Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment","volume":"97","author":"Gertz","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib41","article-title":"Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation","volume":"1","author":"Gonzalez-Lopez","year":"2011","journal-title":"Clin. Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0971-4065.135353","article-title":"Monoclonal gammopathy associated membranous glomerulonephritis: A rare entity","volume":"25","author":"Gowda","year":"2015","journal-title":"Indian J. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","article-title":"A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"94","author":"Gumber","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.critrevonc.2023.103926_bib44","article-title":"A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis","author":"Heybeli","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.critrevonc.2023.103926_bib45","article-title":"Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series","author":"Heybeli","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"156","key":"10.1016\/j.critrevonc.2023.103926_bib46","article-title":"Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma","volume":"15","author":"Hobeika","year":"2014","journal-title":"BMC Nephrol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib47","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2215\/CJN.03160316","article-title":"Bridging the divide: an onco-nephrologic approach to the monoclonal gammopathies of renal significance","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.micron.2008.10.002","article-title":"Optical properties of amyloid stained by Congo red: history and mechanisms","volume":"40","author":"Howie","year":"2009","journal-title":"Micron"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib49","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1159\/000501314","article-title":"Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review","volume":"44","author":"Huang","year":"2019","journal-title":"Kidney Blood Press Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib50","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.critrevonc.2023.103926_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.103926_bib52","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/bloodadvances.2019031914","article-title":"Pathophysiology and management of monoclonal gammopathy of renal significance","volume":"3","author":"Jain","year":"2019","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.kint.2020.06.039","article-title":"Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy","volume":"99","author":"Javaugue","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib55","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103926_bib56","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.transproceed.2009.10.005","article-title":"Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report","volume":"41","author":"Kaposztas","year":"2009","journal-title":"Transpl. Proc."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bjh.17052","article-title":"Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance","volume":"193","author":"Kastritis","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103926_bib59","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2023.103926_bib60","article-title":"Monoclonal gammopathy of renal significance-a rare renal presentation: a review of cases reported","volume":"8","author":"Kichloo","year":"2020","journal-title":"J. Invest. Med High. Impact Case Rep."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103926_bib61","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1681\/ASN.2020010054","article-title":"Rate and predictors of finding monoclonal gammopathy of renal significance (MGRS) lesions on kidney biopsy in patients with monoclonal gammopathy","volume":"31","author":"Klomjit","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"34","key":"10.1016\/j.critrevonc.2023.103926_bib62","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","article-title":"Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis","volume":"31","author":"Kourelis","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib63","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s13730-020-00480-y","article-title":"A case of proliferative glomerulonephritis with immunoglobulin A1-lambda deposits successfully treated by chemotherapy","volume":"9","author":"Kusunoki","year":"2020","journal-title":"CEN Case Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103926_bib64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med"},{"issue":"13","key":"10.1016\/j.critrevonc.2023.103926_bib65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"23","key":"10.1016\/j.critrevonc.2023.103926_bib67","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ajh.23831","article-title":"Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium","volume":"89","author":"Landgren","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103926_bib69","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/modpathol.2011.104","article-title":"The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation","volume":"24","author":"Larsen","year":"2011","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib70","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V100.5.1817.h81702001817_1817_1827","article-title":"Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature","volume":"100","author":"Lebeau","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib71","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2215\/CJN.10641015","article-title":"A patient with abnormal kidney function and a monoclonal light chain in the urine","volume":"11","author":"Leung","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib72","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.00560117","article-title":"Dysproteinemias and glomerular disease","volume":"13","author":"Leung","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"20","key":"10.1016\/j.critrevonc.2023.103926_bib73","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal Gammopathy of Renal Significance","volume":"384","author":"Leung","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2005.05.010","article-title":"Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis","volume":"46","author":"Leung","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib76","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.11161111","article-title":"Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases","volume":"7","author":"Leung","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib78","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib79","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ckj\/sfw090","article-title":"C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome","volume":"9","author":"Lloyd","year":"2016","journal-title":"Clin. Kidney J."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41408-022-00732-3","article-title":"Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study","volume":"12","author":"Long","year":"2022","journal-title":"Blood Cancer J."},{"issue":"16","key":"10.1016\/j.critrevonc.2023.103926_bib81","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1200\/JCO.2011.37.2649","article-title":"Elotuzumab in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma","volume":"30","author":"Lonial","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib82","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/ndt\/gfm918","article-title":"Long-term outcome of autologous stem cell transplantation in light chain deposition disease","volume":"23","author":"Lorenz","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103926_bib83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2010.1","article-title":"Recurrent membranoproliferative glomerulonephritis after kidney transplantation","volume":"77","author":"Lorenz","year":"2010","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121522","article-title":"Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab","volume":"8","author":"Martin","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5301\/JN.2011.6241","article-title":"Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain deposition disease","volume":"24","author":"Matsuzaki","year":"2011","journal-title":"J. Nephrol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib86","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/bloodadvances.2020001553","article-title":"Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function","volume":"4","author":"Milani","year":"2020","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103926_bib87","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.3324\/haematol.2021.278519","article-title":"European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde","volume":"106","author":"Musto","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib89","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.ki.5001990","article-title":"Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis","volume":"65","author":"Nasr","year":"2004","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib91","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ki.5000123","article-title":"Dysproteinemia, proteinuria, and glomerulonephritis","volume":"69","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib92","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib93","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib94","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103926_bib95","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: clinicopathologic and proteomic study","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib97","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","article-title":"The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis","volume":"89","author":"Nasr","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.kint.2019.10.025","article-title":"Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone","volume":"97","author":"Nasr","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.kint.2020.07.037","article-title":"Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants","volume":"99","author":"Nasr","year":"2021","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.23608","article-title":"Long-term outcome of monoclonal (type 1) cryoglobulinemia","volume":"89","author":"Neel","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103926_bib102","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/ndt\/gfh503","article-title":"AL-amyloidosis is underdiagnosed in renal biopsies","volume":"19","author":"Novak","year":"2004","journal-title":"Nephrol. Dial. Transpl."},{"issue":"17","key":"10.1016\/j.critrevonc.2023.103926_bib103","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood-2017-10-810044","article-title":"Single-agent ibrutinib in treatment-naive and relapsed\/refractory chronic lymphocytic leukemia: a 5-year experience","volume":"131","author":"O'Brien","year":"2018","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.critrevonc.2023.103926_bib104","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.103926_bib105","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103926_bib106","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJMoa1606038","article-title":"Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma","volume":"375","author":"Palumbo","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib107","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bjh.15081","article-title":"Treatment with bortezomib in dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"184","author":"Pampa-Saico","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0272-6386(03)00412-8","article-title":"Monoclonal gammopathy: significance and possible causality in renal disease","volume":"42","author":"Paueksakon","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib109","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2017-09-806463","article-title":"First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival","volume":"131","author":"Pika","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib111","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-6143.2012.04326.x","article-title":"Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundance","volume":"13","author":"Pinney","year":"2013","journal-title":"Am. J. Transplant.: Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103926_bib112","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00432-012-1212-4","article-title":"Successful treatment of patients with newly diagnosed\/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone","volume":"138","author":"Ponisch","year":"2012","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103926_bib113","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/j.ajkd.2003.08.040","article-title":"Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors","volume":"42","author":"Pozzi","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib114","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2141.2011.08754.x","article-title":"Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease","volume":"155","author":"Ramasamy","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"9813","key":"10.1016\/j.critrevonc.2023.103926_bib115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib117","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.11080","article-title":"Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"93","author":"Rawstron","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jalm.2019.029330","article-title":"Serum Free Light Chain Assay: Shift Toward a Higher kappa\/lambda Ratio","volume":"5","author":"Rindlisbacher","year":"2020","journal-title":"J. Appl. Lab Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(15)00447-7","article-title":"Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial","volume":"17","author":"Rummel","year":"2016","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103926_bib120","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.thj.6200003","article-title":"Are myeloma patients with renal failure candidates for autologous stem cell transplantation?","volume":"1","author":"San Miguel","year":"2000","journal-title":"Hematol. J."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib122","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/j.ajkd.2006.01.004","article-title":"Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation","volume":"47","author":"Sanada","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"26","key":"10.1016\/j.critrevonc.2023.103926_bib123","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood-2015-07-658872","article-title":"Natural history and outcome of light chain deposition disease","volume":"126","author":"Sayed","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib124","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MNH.0000000000000201","article-title":"Spectrum of manifestations of monoclonal gammopathy-associated renal lesions","volume":"25","author":"Sethi","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib125","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib126","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib127","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2003.10.036","article-title":"Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma","volume":"43","author":"Shah","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib128","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2023.103926_bib129","article-title":"Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance","author":"Sprangers","year":"2022","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ekir.2020.01.019","article-title":"Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients","volume":"5","author":"Sprangers","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib131","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.18632\/oncotarget.23412","article-title":"Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients","volume":"9","author":"Steiner","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib132","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era","volume":"27","author":"Stokes","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.critrevonc.2023.103926_bib133","first-page":"1","article-title":"Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review","author":"Terao","year":"2022","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103926_bib134","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Med. (Baltim. )."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2016-03-705210","article-title":"Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma","volume":"128","author":"Usmani","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib136","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.kint.2016.10.026","article-title":"The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits","volume":"91","author":"Vignon","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103926_bib137","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.4519","article-title":"Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis","volume":"4","author":"Waxman","year":"2018","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103926_bib138","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2215\/CJN.12890921","article-title":"Kidney histopathologic spectrum and clinical indicators associated with MGRS","volume":"17","author":"Yong","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib139","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1681\/ASN.2020101541","article-title":"Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits","volume":"32","author":"Zand","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103926_bib140","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1038\/s41598-017-13486-x","article-title":"The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-beta1","volume":"7","author":"Zeniya","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103926_bib141","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.ajkd.2019.08.013","article-title":"Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series","volume":"75","author":"Zhang","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103926_bib142","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198222","article-title":"Henoch-Schonlein purpura nephritis associated with monoclonal gammopathy of renal significance: a case report","volume":"52","author":"Zhao","year":"2019","journal-title":"Braz. J. Med Biol. Res"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:47:26Z","timestamp":1760903246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":142,"alternative-id":["S1040842823000148"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103926","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103926"}}